1. Zhang K, Shan L, Rahman MS, Unruh H, Halayko AJ, Gounni AS. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2007; 293:L375–L382.
2. Ziegler SF. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr Opin Immunol. 2010; 22:795–799.
3. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med. 2006; 203:269–273.
4. Ying S, O'Connor B, Ratoff J, Meng Q, Fang C, Cousins D, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008; 181:2790–2798.
5. Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, et al. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011; 3:186–193.
6. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol. 1999; 20:777–786.
7. Nomura K, Kojima T, Fuchimoto J, Obata K, Keira T, Himi T, et al. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. Laryngoscope. 2012; 122:1185–1192.
8. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol. 2009; 183:1427–1434.
9. Shin SH, Lee YH. Airborne fungi induce nasal polyp epithelial cell activation and toll-like receptor expression. Int Arch Allergy Immunol. 2010; 153:46–52.
10. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50:1–12.
11. Fukumoto A, Nonaka M, Ogihara N, Pawankar R. Induction of TARC production by lipopolysaccharide and interleukin-4 in nasal fibroblasts. Int Arch Allergy Immunol. 2008; 145:291–297.
12. Shin SH, Ye MK, Kim JK. Effects of fungi and eosinophils on mucin gene expression in rhinovirus-infected nasal epithelial cells. Allergy Asthma Immunol Res. 2014; 6:149–155.
13. Shin SH, Ye MK, Lee YH. Fungus culture of the nasal secretion of chronic rhinosinusitis patients: seasonal variations in Daegu, Korea. Am J Rhinol. 2007; 21:556–559.
14. Janssens S, Beyaert R. Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003; 16:637–646.
15. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Tolllike receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007; 7:1271–1285.
16. Dong Z, Yang Z, Wang C. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am J Rhinol. 2005; 19:236–239.
17. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med. 2003; 197:1107–1117.
18. Ozawa T, Koyama K, Ando T, Ohnuma Y, Hatsushika K, Ohba T, et al. Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-κB pathway and interferon-γ/dexamethasone. Mod Rheumatol. 2007; 17:459–463.